companiesCompany
PharmaMar
Spanish company that turns marine natural products into cancer drugs, including lurbinectedin and trabectedin.
Discovered lurbinectedin (Zepzelca, partnered with Jazz in the US) and trabectedin (Yondelis). IMforte success in 2025 broadened lurbinectedin into first-line maintenance.
Pages like this
not linked directly; found by shared links- TrialATLANTIS
Shares Lurbinectedin, Small-cell lung cancer.
- TrialIMforte
Shares Lurbinectedin, Small-cell lung cancer.
- TrialIDeate-Lung02
Shares Lurbinectedin, Small-cell lung cancer.
- TargetEWSR1-FLI1 fusion
Shares Lurbinectedin, Ewing sarcoma, Sarcomas (soft tissue, bone, GIST).
- CompanyJazz Pharmaceuticals
Shares Lurbinectedin, Ewing sarcoma, Small-cell lung cancer.
- PairingChemo-immunotherapy induction → maintenance intensification (SCLC)
Shares Lurbinectedin, Small-cell lung cancer.
- TechnologyLimb-salvage surgery and endoprosthetic reconstruction
- ProductTopotecan
Shares Ewing sarcoma, Small-cell lung cancer.